Beta-3 adrenoceptor-mediated increase in cutaneous blood flow in the dog

M Berlan, J Galitzky, A Bousquet-Melou, M Lafontan and JL Montastruc

Laboratoire de Pharmacologie Medicale et Clinique, Institut National de la Sante et de la Recherche Medicale, Unite 317, Faculte de Medecine, Toulouse, France.

Beta-3 adrenergic agonist administration decreases arterial blood pressure in the dog as previously shown. The putative presence of beta- 3 adrenoceptors in peripheral microvascular muscle was studied in dogs through measurement of cutaneous blood flow and skin temperature changes. Experiments were carried out in normal and sinoaortic denervated dogs (i.e., animals deprived of baroreceptor pathways). In normal dogs, the infusion of 0.4 nmol/kg/min of 4-[-[(2-hydroxy-(3- chlorophenyl)ethyl)-amino]propyl] phenoxyacetate (BRL 37344) or (R,R-5- [2-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]propyl]-1,3- benzodioxole- 2,2-dicarboxylate (CL 316243) (two selective beta-3 adrenoceptor agonists), or 8 nmol/kg/min of 4-[3-t-butylamino-2- hydroxypropoxy]benzimidazol-2-one (CGP 12177) (a beta-1/beta-2 adrenergic antagonist also reported to act as an agonist for the beta-3 adrenoceptor) induced an increase in heart rate and cutaneous blood flow (evaluated in the internal part of the ear) and a decrease in blood pressure. The skin and the buccal mucous membrane became purplish. The infusion of (-)-isoproterenol (0.4 nmol/g/min), a dose known to stimulate preferentially beta-1/beta-2 adrenoceptors, or sodium nitroprusside (12 micrograms/kg/min) increased heart rate and decreased blood pressure, but reduced cutaneous blood flow. In sinoaortic denervated dogs, similar effects on cutaneous blood flow and blood pressure were observed. However, in these animals, heart rate remained unchanged whatever the infused drug. BRL 37344 (but not isoproterenol) increased cutaneous temperature in normal dogs. This study suggests that beta-3 adrenoceptors exist in canine cutaneous vascular smooth muscles and that their stimulation induces vasodilatation.

Volume 268, Issue 3, pp. 1444-1451, 03/01/1994
Copyright © 1994 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				C. Rouget, O. Barthez, F. Goirand, M.J. Leroy, M. Breuiller-Fouche, Z. Rakotoniaina, P. Guerard, E.J. Morcillo, C. Advenier, P. Sagot, et al. Stimulation of the ADRB3 Adrenergic Receptor Induces Relaxation of Human Placental Arteries: Influence of Preeclampsia Biol Reprod, January 1, 2006; 74(1): 209 - 216. [Abstract] [Full Text] [PDF]

				B. Rozec, S. Serpillon, G. Toumaniantz, C. Seze, Y. Rautureau, O. Baron, J. Noireaud, and C. Gauthier Characterization of Beta3-Adrenoceptors in Human Internal Mammary Artery and Putative Involvement in Coronary Artery Bypass Management J. Am. Coll. Cardiol., July 19, 2005; 46(2): 351 - 359. [Abstract] [Full Text] [PDF]

				C. Dessy, S. Moniotte, P. Ghisdal, X. Havaux, P. Noirhomme, and J.L. Balligand Endothelial {beta}3-Adrenoceptors Mediate Vasorelaxation of Human Coronary Microarteries Through Nitric Oxide and Endothelium-Dependent Hyperpolarization Circulation, August 24, 2004; 110(8): 948 - 954. [Abstract] [Full Text] [PDF]

				V. Leblais, F. Pourageaud, M. D. Ivorra, C. Guibert, R. Marthan, and B. Muller Role of {alpha}-Adrenergic Receptors in the Effect of the {beta}-Adrenergic Receptor Ligands, CGP 12177, Bupranolol, and SR 59230A, on the Contraction of Rat Intrapulmonary Artery J. Pharmacol. Exp. Ther., April 1, 2004; 309(1): 137 - 145. [Abstract] [Full Text]

				M. Pelat, P. Verwaerde, J. Galitzky, M. Lafontan, M. Berlan, J.-M. Senard, and J.-L. Montastruc High Isoproterenol Doses Are Required to Activate beta 3-Adrenoceptor-Mediated Functions in Dogs J. Pharmacol. Exp. Ther., January 1, 2003; 304(1): 246 - 253. [Abstract] [Full Text] [PDF]

				S. Guimaraes and D. Moura Vascular Adrenoceptors: An Update Pharmacol. Rev., June 1, 2001; 53(2): 319 - 356. [Abstract] [Full Text] [PDF]

				G. J. Hom, M. J. Forrest, T. J. Bach, E. Brady, M. R. Candelore, M. A. Cascieri, D. J. Fletcher, M. H. Fisher, S. A. Iliff, R. Mathvink, et al. {beta}3-Adrenoceptor Agonist-Induced Increases in Lipolysis, Metabolic Rate, Facial Flushing, and Reflex Tachycardia in Anesthetized Rhesus Monkeys J. Pharmacol. Exp. Ther., April 1, 2001; 297(1): 299 - 307. [Abstract] [Full Text]

				C. Gauthier, G. Tavernier, J.-N. Trochu, V. Leblais, K. Laurent, D. Langin, D. Escande, and H. Le Marec Interspecies Differences in the Cardiac Negative Inotropic Effects of beta 3-Adrenoceptor Agonists J. Pharmacol. Exp. Ther., August 1, 1999; 290(2): 687 - 693. [Abstract] [Full Text]

				N. Shihara, K. Yasuda, T. Moritani, H. Ue, T. Adachi, H. Tanaka, K. Tsuda, and Y. Seino The Association between Trp64Arg Polymorphism of the {beta}3-Adrenergic Receptor and Autonomic Nervous System Activity J. Clin. Endocrinol. Metab., May 1, 1999; 84(5): 1623 - 1627. [Abstract] [Full Text]

				G. Sokoloff, R. F. Kirby, and M. S. Blumberg Further evidence that BAT thermogenesis modulates cardiac rate in infant rats Am J Physiol Regulatory Integrative Comp Physiol, June 1, 1998; 274(6): R1712 - R1717. [Abstract] [Full Text] [PDF]

				P. Barbe, V. Stich, J. Galitzky, M. Kunesova, V. Hainer, M. Lafontan, and M. Berlan In Vivo Increase in {beta}-Adrenergic Lipolytic Response in Subcutaneous Adipose Tissue of Obese Subjects Submitted to a Hypocaloric Diet J. Clin. Endocrinol. Metab., January 1, 1997; 82(1): 63 - 69. [Abstract] [Full Text] [PDF]